Neumora Therapeutics (NMRA) traded down -6.65 % during a 24 hours period ending at 11:44 PM Central Europe on Monday 26th. One Neumora Therapeutics stock can currently be bought for about USD 0.39 on popular exchanges. Current supply of Neumora Therapeutics stocks is 187.9 mn. Neumora Therapeutics has a current market capitalization of USD 71.3 mn and approximately USD 314.9 k worth of Neumora Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Neumora Therapeutics has traded -46.09 % down. Simple moving average of last 200 days is at USD 1.82. The highest price of past 52 weeks was recorded at USD 3.65 on 02/18/2026. 52 weeks low was at USD 0.32 on 10/14/2026.
Here is how related stocks have performed in the past 24 hours:
Mays (MAYS) traded up 3.8 % and now trades at USD 42.93. Current market capitalisation for Mays is USD 82.6 mn.
Stonebridge Acquisition Cl (APAC) traded up 0.1 % and now trades at USD 10.28. Stonebridge Acquisition Cl has a market capitalisation of USD 82.8 mn. Current price/earnings ratio for Stonebridge Acquisition Cl is 109.13.
Inspired Entertainment (INSE) traded down -2.76 % and now trades at USD 3.18. Current market capitalisation for Inspired Entertainment is USD 83.6 mn. Current price/earnings ratio for Inspired Entertainment is 64.13.
Stabilis (SLNG) traded up 2.76 % and now trades at USD 4.45. Current market capitalisation for Stabilis is USD 82.9 mn.
Rani Therapeutics (RANI) traded up 3.06 % and now trades at USD 0.62. Rani Therapeutics has a market capitalisation of USD 85.1 mn.
About Neumora Therapeutics
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Watertown, United States. The company specializes in discovering, developing, and commercializing targeted therapies for the treatment of people living with brain diseases. Their mission is to revolutionize the way these diseases are managed, ultimately improving patient outcomes and quality of life.
